NanoVibronix has extended its distribution agreement with MDS. Pharm, NanoVibronix’s current PainShield and WoundShield distributor in Israel, to sell its UroShield in the country.
Image: NanoVibronix extends agreement with MDS Pharm to sell UroShield in Israel. Photo: Courtesy of adamr at FreeDigitalPhotos.net
MDS Pharm Ltd. is a leading distributor of medical equipment for home-care and self-diagnostics. An integral element of the company’s mission is to provide customers with alternatives to medication and/or pain relief drugs.
MDS has an established distribution network in Israel that includes health insurance providers, private pharmacies, health stores, beautician centers, private clinics, and leading health websites.
UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI). UroShield is also intended to decrease pain and discomfort associated with urinary catheter use.
MDS Pharm CEO Dorit Grinberg said: “We are pleased to add an additional product line to our existing distribution agreement, strengthening the partnership between our companies. This enables MDS to take further steps towards our mission of providing customers with alternatives to medication, in this case potentially preventing the need for antibiotics that would traditionally be used to combat catheter associated urinary tract infections.”
NanoVibronix CEO Brian Murphy said: “We are excited to have UroShield as an additional product for distribution in Israel, as catheter-associated UTIs accounted for approximately 50% of healthcare acquired bacteremia in long term care facilities. Israel is an attractive market for our products and MDS brings an established distribution network.”
Source: Company Press Release